These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20584905)

  • 1. Isoform-specific prolongation of Kv7 (KCNQ) potassium channel opening mediated by new molecular determinants for drug-channel interactions.
    Gao Z; Zhang T; Wu M; Xiong Q; Sun H; Zhang Y; Zu L; Wang W; Li M
    J Biol Chem; 2010 Sep; 285(36):28322-32. PubMed ID: 20584905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence determinants of subtype-specific actions of KCNQ channel openers.
    Wang AW; Yang R; Kurata HT
    J Physiol; 2017 Feb; 595(3):663-676. PubMed ID: 27506413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of M-type KCNQ (Kv7) K+ channel assembly.
    Schwake M; Athanasiadu D; Beimgraben C; Blanz J; Beck C; Jentsch TJ; Saftig P; Friedrich T
    J Neurosci; 2006 Apr; 26(14):3757-66. PubMed ID: 16597729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
    Padilla K; Wickenden AD; Gerlach AC; McCormack K
    Neurosci Lett; 2009 Nov; 465(2):138-42. PubMed ID: 19733209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.
    Zhang D; Thimmapaya R; Zhang XF; Anderson DJ; Baranowski JL; Scanio M; Perez-Medrano A; Peddi S; Wang Z; Patel JR; DeGoey DA; Gopalakrishnan M; Honore P; Yao BB; Surowy CS
    J Neurosci Methods; 2011 Aug; 200(1):54-62. PubMed ID: 21723881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers.
    Xiong Q; Sun H; Zhang Y; Nan F; Li M
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3128-33. PubMed ID: 18272489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants.
    Xiong Q; Sun H; Li M
    Nat Chem Biol; 2007 May; 3(5):287-96. PubMed ID: 17435769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
    Qi J; Zhang F; Mi Y; Fu Y; Xu W; Zhang D; Wu Y; Du X; Jia Q; Wang K; Zhang H
    Eur J Med Chem; 2011 Mar; 46(3):934-43. PubMed ID: 21296466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy.
    Zhang F; Liu Y; Tang F; Liang B; Chen H; Zhang H; Wang K
    FASEB J; 2019 Aug; 33(8):9154-9166. PubMed ID: 31063701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators.
    Kumar M; Reed N; Liu R; Aizenman E; Wipf P; Tzounopoulos T
    Mol Pharmacol; 2016 Jun; 89(6):667-77. PubMed ID: 27005699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate.
    Li Y; Gamper N; Hilgemann DW; Shapiro MS
    J Neurosci; 2005 Oct; 25(43):9825-35. PubMed ID: 16251430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acrylamide (S)-2 as a positive and negative modulator of Kv7 channels expressed in Xenopus laevis oocytes.
    Blom SM; Schmitt N; Jensen HS
    PLoS One; 2009 Dec; 4(12):e8251. PubMed ID: 20011514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and function of KCNQ potassium channels in human chorionic plate arteries from women with normal pregnancies and pre-eclampsia.
    Wei X; Zhang Y; Yin B; Wen J; Cheng J; Fu X
    PLoS One; 2018; 13(3):e0192122. PubMed ID: 29579054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an automated screen for Kv7.2 potassium channels and discovery of a new agonist chemotype.
    Hernandez CC; Tarfa RA; Miguel I Limcaoco J; Liu R; Mondal P; Hill C; Keith Duncan R; Tzounopoulos T; Stephenson CRJ; O'Meara MJ; Wipf P
    Bioorg Med Chem Lett; 2022 Sep; 71():128841. PubMed ID: 35671848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sensorless Pore Module of Voltage-gated K+ Channel Family 7 Embodies the Target Site for the Anticonvulsant Retigabine.
    Syeda R; Santos JS; Montal M
    J Biol Chem; 2016 Feb; 291(6):2931-7. PubMed ID: 26627826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Calmodulin Regulation of Different Isoforms of Kv7.4 K+ Channels.
    Sihn CR; Kim HJ; Woltz RL; Yarov-Yarovoy V; Yang PC; Xu J; Clancy CE; Zhang XD; Chiamvimonvat N; Yamoah EN
    J Biol Chem; 2016 Jan; 291(5):2499-509. PubMed ID: 26515070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteromeric Assembly of Truncated Neuronal Kv7 Channels: Implications for Neurologic Disease and Pharmacotherapy.
    Li J; Maghera J; Lamothe SM; Marco EJ; Kurata HT
    Mol Pharmacol; 2020 Sep; 98(3):192-202. PubMed ID: 32580997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMIT1 Modifies KCNQ Channel Function and Pharmacology by Physical Interaction with the Pore.
    Manville RW; Neverisky DL; Abbott GW
    Biophys J; 2017 Aug; 113(3):613-626. PubMed ID: 28793216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and behavioral signatures of Kv7 activator drug subtypes.
    Kanyo R; Wang CK; Locskai LF; Li J; Allison WT; Kurata HT
    Epilepsia; 2020 Aug; 61(8):1678-1690. PubMed ID: 32652600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Calmodulin C-Lobe Ca
    Chang A; Abderemane-Ali F; Hura GL; Rossen ND; Gate RE; Minor DL
    Neuron; 2018 Feb; 97(4):836-852.e6. PubMed ID: 29429937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.